Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)
Blue Water Biotech, Inc. (Nasdaq: BWV) has regained compliance with Nasdaq Listing Rule 5250(c)(1) after filing its Form 10-Q for the period ended June 30, 2023. The company is now current on its SEC financial reporting obligations.
11/01/2023 - 07:00 AM
CINCINNATI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced that it has received a letter from the Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the Nasdaq Stock Market, LLC Listing Rule 5250(c)(1) (the "Rule").
The Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (SEC). On October 20, 2023, BWB filed its Form 10-Q for the period ended June 30, 2023, and thus is now current on its SEC financial reporting obligations.
About Blue Water Biotech, Inc.
Blue Water Biotech, Inc. is a commercial stage biotechnology company focused on the research, development, and commercialization of innovative solutions for oncology. The Company currently has Entadfi®, an oral therapeutic for the treatment of benign prostatic hyperplasia (BPH), a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Investor and Media Contact Information:
Russo Partners, LLC Nic.Johnson@russopartnersllc.com
What is the company name mentioned in the press release?
The company mentioned in the press release is Blue Water Biotech, Inc. (Nasdaq: BWV).
What rule did Blue Water Biotech regain compliance with?
Blue Water Biotech regained compliance with Nasdaq Listing Rule 5250(c)(1).
What did Blue Water Biotech file to regain compliance?
Blue Water Biotech filed its Form 10-Q for the period ended June 30, 2023.
What does being current on SEC financial reporting obligations mean?
Being current on SEC financial reporting obligations means that the company has timely filed all required periodic financial reports with the Securities and Exchange Commission.
Blue Water Biotech Inc
NASDAQ:BWV
BWV Rankings
N/A Ranked by Stock Gains
BWV Stock Data
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
Country
US
City
Cincinnati
About BWV
developed by scientists at the prestigious oxford university in the uk, our vaccine protects against all influenza strains. it targets parts of the virus that are easy to induce a protective immune response against but also limited in variability. these regions of the virus were shown in thompson et al 2018 to direct the antigenic evolution of the influenza virus and therefore make ideal vaccine targets. the vaccine thus negates the need for (i) annual vaccination, providing potentially life-long protection against flu, and (ii) reformulation of the vaccine every few years.
